Article Information
History
- September 18, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Barbara Fraser1,2,3,
- Alex Wilkins1,2,3,
- Sara Whiting1,2,3,
- Mingtao Liang4,5,
- Diane Rebourcet1,2,3,
- Brett Nixon1,2,3 and
- R. John Aitken1,2,3,*
- 1Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW, Australia, 2308
- 2Pregnancy and Reproduction Program, Hunter Medical Research Institute, Kookaburra Cct, New Lambton Heights NSW, Australia 2305
- 3College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW 2308
- 4School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, 2308
- 5College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308
- ↵*Correspondence: John.Aitken{at}newcastle.edu.au
Posted September 18, 2023.
Development of peptides for targeting cell ablation agents concurrently to the Sertoli and Leydig cell populations of the testes: an approach to non-surgical sterilization
